Literature DB >> 6298174

Combined activity of ketoconazole and sulphamethoxazole against Candida albicans.

W H Beggs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6298174     DOI： 10.1093/jac/10.6.539

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  5 in total

1.  In vitro activities of pentamidine, pyrimethamine, trimethoprim, and sulfonamides against Aspergillus species.

Authors:  Javier Afeltra; Jacques F G M Meis; Roxana G Vitale; Johan W Mouton; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

Review 2.  Antifungal activity of nonantifungal drugs.

Authors:  J Afeltra; P E Verweij
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-06-26       Impact factor: 3.267

3.  Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection.

Authors:  Ronen Ben-Ami; Keren Olshtain-Pops; Michal Krieger; Ilana Oren; Jihad Bishara; Michael Dan; Yonit Wiener-Well; Miriam Weinberger; Oren Zimhony; Michal Chowers; Gabriel Weber; Israel Potasman; Bibiana Chazan; Imad Kassis; Itamar Shalit; Colin Block; Nathan Keller; Dimitrios P Kontoyiannis; Michael Giladi
Journal:  Antimicrob Agents Chemother       Date:  2012-02-06       Impact factor: 5.191

Review 4.  Direct effects of non-antifungal agents used in cancer chemotherapy and organ transplantation on the development and virulence of Candida and Aspergillus species.

Authors:  Sharon C-A Chen; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Virulence       Date:  2011-07-01       Impact factor: 5.882

5.  Reversal of Azole Resistance in Candida albicans by Sulfa Antibacterial Drugs.

Authors:  Hassan E Eldesouky; Abdelrahman Mayhoub; Tony R Hazbun; Mohamed N Seleem
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.